A Study to Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers

Clinical trial NCT03446053 · COMPLETED

Trial details

NCT number: NCT03446053
Sponsor: Intron Biotechnology, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Anti-Bacterial Agents Methicillin-Resistant Staphylococcus Aureus Methicillin-Sensitive Staphylococcus Aureus Infection

Start date: 2018-02-07
Primary completion: 2019-02-07
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.